Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

George N Pavlakis

20PUBLICATIONS
101CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesInnate immunityPredictive and prognostic markersEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

Sort by Publication Date:
|Oct 31, 2023
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.

Rom Leidner, Kevin Conlon, Douglas G McNeel

|Feb 22, 2023
XBB.1.5 neutralizing antibodies upon bivalent COVID-19 vaccination are similar to XBB but lower than BQ.1.1.

Santhi Devasundaram, Evangelos Terpos, Margherita Rosati

|Dec 11, 2022
Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom's Macroglobulinemia after BNT162b2 Booster Vaccination.

Margherita Rosati, Evangelos Terpos, Jenifer Bear

|Oct 27, 2022
Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network.

Christina Papanikolaou, Vasiliki Rapti, Dimitris Stellas

|Apr 21, 2022
Evaluating the effects of second-dose vaccine-delay policies in European countries: A simulation study based on data from Greece.

Petros Barmpounakis, Nikolaos Demiris, Ioannis Kontoyiannis

|Nov 20, 2021
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors.

Kevin Conlon, Dionysios C Watson, Thomas A Waldmann

Pageof 4

Frequent Collaborators

12 joint publications

Barbara K Felber

11 joint publications

Jenifer Bear

8 joint publications

Margherita Rosati

6 joint publications

Evangelos Terpos

6 joint publications

Dimitris Stellas

5 joint publications

Meletios-Athanasios Dimopoulos

5 joint publications

Xintao Hu

4 joint publications

David J Venzon

3 joint publications

Dionysios C Watson

3 joint publications

Cristina Bergamaschi

Frequent Collaborators

12 joint publications

Barbara K Felber

11 joint publications

Jenifer Bear

8 joint publications

Margherita Rosati

6 joint publications

Evangelos Terpos

Top Related Videos

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on : Mar 13, 2018

12.1K
Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies
06:08

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on : Sep 08, 2023

1.3K
Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens
06:03

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens

Published on : Sep 20, 2024

1.4K
See more related videos

Top Related Videos

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on : Mar 13, 2018

12.1K
Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies
06:08

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on : Sep 08, 2023

1.3K
Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens
06:03

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens

Published on : Sep 20, 2024

1.4K
See more related videos